Monoclonal Antibody Therapy

Monoclonal antibody therapy is a process in which monoclonal antibodies (mAb) are used to bind monospecifically to certain cells or proteins. This may then stimulate the patient's immune system to attack those cells. Alternatively, in radioimmunotherapy a radioactive dose localizes on a target cell line, delivering lethal chemical doses. More recently antibodies have been used to bind to molecules involved in T-cell regulation to remove inhibitory pathways that block T-cell responses, known as immune checkpoint therapy. It is possible to create a mAb specific to almost any extracellular/ cell surface target. Research and development is underway to create antibodies for diseases (such as rheumatoid arthritis, multiple sclerosis, Alzheimer's disease, Ebola and different types of cancers).    

  • Advantages in Monoclonal Antibody Therapy
  • Monoclonal and Polyclonal antibodies
  • Monoclonal Antibody Therapy for Cancer
  • Monoclonal Antibodies Applications
  • Hybridoma Technology and Monoclonal Antibody Preparation
  • Antibody Research in Agriculture, Aquaculture, Veterinary and Food Sciences
  • Antibody Technology in New Protein Discovery

Related Conference of Monoclonal Antibody Therapy

June 13-14, 2019 |

10th European Immunology Conference

Berlin, Germany
July 29-30 2019

6th International Conference on Parasitology & Microbiology

Amsterdam, Netherlands
July 29-30, 2019

11th Global Summit on Immunology and Cell Biology

Sydney, Australia
November 12-13, 2019

13th International Congress on Autoimmunity

Brisbane, Australia
November 21-22, 2019

World Conference on Vaccine and Immunology

Dubai, UAE
November 25-26 , 2019

Global meet on Immunology and Molecular Biology

Paris, France
November 28-29, 2019

International Conference on Vaccines and Immune Response

Helsinki, Finland

Monoclonal Antibody Therapy Conference Speakers

Recommended Sessions

Related Journals

Are you interested in